A clinical trial that has widespread clinical applications may receive little if any attention. In his
HIV and ID Observations blog, Dr. Paul Sax explains why.
Which is better for the treatment of skin and soft tissue infections — clindamycin or trimethroprim/sulfamethoxazole? In his HIV and ID Observations blog, Dr. Paul Sax describes the outcome of a clinical trial involving these two drugs that was presented at the ID conference ICAAC last week. He then explains why the “undoubtedly . . . useful” study won't get the attention it deserves.